Skip to main content
. 2021 Aug 26;10:126. doi: 10.1186/s13756-021-00995-8

Table 1.

Drug susceptibility profiles of MDR-TB isolates enrolled in this study

Drug susceptibility profile No. of isolates Proportion (%)
INH + RIF 86 20.2
INH + RIF + FQ 168 39.5
INH + RIF + SLID 28 6.6
INH + RIF + FQ + SLID 143 33.6
Total 425 100.0

INH, isoniazid; RIF, rifampicin; FQ, fluoroquinolone; SLID, second-line injectable drugs